Pulmonary Medicine

Diagnostic Bronchoscopy

General description of procedure, equipment, technique

This presentation provides a brief overview of diagnostic bronchoscopy, with a focus on the flexible fiberoptic technique.

The first direct endoscopic examination of the larynx was performed by Kirstein in 1895. Two years later, Gustav Killian, the "father of bronchoscopy,” investigated the lower trachea and main bronchi using Kirstein's laryngoscope.

In 1964, Dr. Shigeto Ikeda established standards for flexible fiberoptic bronchoscopy, and by 1966, bronchoscope prototypes had been developed. In 1968, the first commercially available flexible fiberoptic bronchoscope was introduced. In 1987, Dr. Ikeda introduced video bronchoscopy by replacing the bronchoscope's optical fiber bundle with a charge-coupled device (CCD), thereby providing improved image resolution.

Flexible fiberoptic bronchoscopy (FOB) is the most commonly performed method of bronchoscopy. Rigid bronchoscopy is performed under general anesthesia and is mainly therapeutic in nature.

During bronchoscopy, the operator visualizes the vocal cords, trachea, large proximal airways, and smaller distal airways to the level of the third or fourth generation of airways. FOB is used to sample and treat lesions in airways and to sample the lung parenchyma.

FOB is generally performed in a designated procedure room, with the patient under conscious sedation, with or without an endotracheal tube in place. The bronchoscope consists of a flexible sheath that contains cables that allow the tip of the device to be flexed or extended. Images are transmitted using a CCD chip or through fiberoptic bundles. The bronchoscope includes a light source and a working channel for removal of secretions, insertion of biopsy forceps or aspirating needle, or performance of lung lavage.

Indications and patient selection

Bronchoscopy is used in evaluating a wide variety of clinical circumstances, including known or suspected malignancy (diagnosis, staging, follow-up evaluation of abnormal sputum studies, patient follow-up after treatment, and assessment of metastatic carcinoma); evaluation of interstitial lung diseases; evaluation of known or suspected respiratory infections, recurrent or unresolved pneumonia, assessment of infiltrates in an immuno-compromised host, exploration of cavitary lung lesions; diagnostic assessment of unexplained lung collapse; and evaluation of a variety of respiratory symptoms and signs, including hemoptysis, unexplained chronic cough, localized wheezing, and stridor.

Brochoscopy is also used as a diagnostic and potential therapeutic approach in suspected or documented foreign body aspiration; in evaluation of unexplained pleural effusion; and as diagnostic tool in lung transplantation, including donor assessment, evaluation of the transplanted organ for stricture or stenosis at the anastamotic site, or infection or rejection.

In addition, brochoscopy is used in patient evaluation in the setting of chest trauma, either blunt or penetrating; assessment for chemical or thermal lung injury; in conjunction with endotracheal intubation, including assistance in performing difficult intubations, confirmation of endotracheal tube or tracheostomy tube position, evaluation for tube-related injury, confirmation of transtracheal oxygen catheter position, or as an adjunct in performing percutaneous tracheostomy.

Other uses of bronchoscopy include visual assessment of bronchopleural, tracheo-esophageal, or broncho-esophageal fistulae; as part of the post-operative assessment of tracheal or bronchial anastomoses or determination of the integrity of the bronchial stump following lung resection; and as part of a program of pulmonary toilet in the setting of lobar or lung collapse, usually in the setting of excessive respiratory secretions.


Bronchoscopy must be carefully considered from the perspective of risk versus benefit. Contraindications to the procedure include inadequate oxygenation, use of anticoagulants and antiplatelet agents, unstable neck, severely ankylosed cervical spine, and restricted temporomandibular joint.

Additional, relative contraindications include malignant arrhythmia, unstable cardiac status, refractory hypoxia, bleeding diathesis (especially when biopsy is anticipated), uremia, and untreated tuberculosis.

Factors associated with increased risk of complications from bronchoscopy include an uncooperative patient, recent or unstable angina, moderate hypoxia, hypercarbia, uremia, lung abscess, immunosuppression, debility, advanced age, and malnutrition.

Details of how the procedure is performed

The core elements in performing flexible fiberoptic bronchoscopy includes administration of patient sedation, which commonly includes benzodiazepines like midazolam or lorazepam, though opiates may also be employed. Deep sedation may be performed using propofol, hydroxyzine, or droperidol, as adequate sedation is important for patient comfort, physician comfort, and as a means of increasing the patient's willingness to undergo a repeat procedure, if clinically necessary.

Use of a local, topical anesthesia like lidocaine using either a nebulizer or aerosol spray is important. Injection of a 1 percent lidocaine solution through the bronchoscope into the trachea and large proximal airways and onto the main carina helps with cough suppression. The total dose of lidocaine should be limited to 8.2 mg/kg in adults, with extra care exercised in the elderly and in those with liver or cardiac impairment. Lidocaine-related side effects include arrhythmias, seizures, cardiorespiratory arrest, and death. Plasma drug levels correlate with the total dose administered during bronchoscopy.

Patient monitoring during the procedure includes pulse oximetry, cardiac monitoring, and periodic measurement of blood pressure.

The bronchoscope may be inserted transnasally, orally, or via an artificial airway, including an endotracheal or tracheostomy tube. Bronchial washing may be performed for securing cytology specimens. Bronchiolar lavage (BAL) may be performed following airway inspection and prior to biopsy or brushing. BAL, which enables procurement of samples from the distal airways and alveoli, differs from bronchial washing, in which secretions are aspirated from large airways directly or following the instillation of 10 to 30 ml of saline.

BAL is performed in the lung region with the most prominent radiographic involvement. In diffuse disease, the right middle lobe or lingula is usually lavaged. Use of 100 ml fluid aliquots permits sampling of approximately one million alveoli (1.5 to 3% of the lung). During the lavage, the bronchoscope is advanced into a subsegmental bronchus until the lumen is occluded (the "wedged" position). A good wedge position is usually confirmed by noting slight airway collapse when gentle suction is applied. Poor wedge position allows leakage of lavage fluid.

Total fluid volume to be instilled has not been standardized but 100 to 240 ml of fluid in 20 to 60 ml aliquots is typically used. In evaluation of diffuse alveolar hemorrhage (DAH), three sequential lavages should be performed at the same site. Samples are visually inspected for any increase in hemorrhagic appearance from the first to the last specimen, and the procedure should be terminated if substantial distress (e.g., excessive coughing) or falling oxygen saturation are observed.

BAL is also useful in evaluating immunocompromised hosts with pulmonary infiltrates.

Bronchial brush biopsy is performed by extending an initially retracted brush encased within a Teflon sheath into the abnormal airway. The technique is useful in evaluating a visible endobronchial mass or suspected tumor.

Endobronchial biopsy utilizes forceps (including cup-, alligator-, and needle-type forceps) to obtain biopsies of visible endobronchial lesions. The forceps are opened and applied directly to the lesion using gentle, firm pressure. As tissue is engaged, the forceps are closed and "tugged" before being withdrawn through the bronchoscope.

Transbronchial lung biopsy is performed by selecting the segmental bronchus through which the forceps are to be passed. A 5-ml bolus of diluted epinephrine is injected prior to advancing the forceps. As the forceps disappear from direct view through the bronchoscope, the operator relies on fluoroscopic control to localize the forceps and takes care to avoid the visceral pleura. The forceps are anchored at the bifurcation of a respiratory bronchiole, closed, and then tugged. A sample of lung parenchyma is obtained by effectively tearing respiratory bronchioles. Optimally, 4-6 specimens should be obtained.

Interpretation of results

Accurate interpretation of cytologic, microbiologic, and pathologic findings from diagnostic bronchoscopy is critical to appropriate patient management.

Performance characteristics of the procedure (applies only to diagnostic procedures)

Not applicable.

Outcomes (applies only to therapeutic procedures)

Not applicable.

Alternative and/or additional procedures to consider

Alternative diagnostic procedures may include surgical approaches like VATS lung biopsy, surgical mediastinal lymph node sampling, and transthoracic needle aspiration, all of which are discussed elsewhere.

Complications and their management

A number of well recognized complications of diagnostic bronchoscopy should be noted. Use of topical lidocaine anesthesia may result in complications when the dose exceeds the maximum of 4 mg/kg. If Methemoglobinemia is seen, it is treated with 1 percent methylene blue (1mg/kg intravenously over five minutes, followed by a second dose at thirty minutes, along with ascorbic acid, 2 gm orally). Laryngospasm and bronchospasm are treated with aerosolized albuterol.

Bleeding exceeding 50 ml occurs in 1-4 percent of procedures, with mechanical trauma (from use of a brush catheter or biopsy forceps) the most common cause. The presence of a vascular lesion may be contributory, and bleeding diatheses, uremia, or a platelet count less than 50,000 per cm3 may predispose to bleeding.

Management of bleeding includes putting the patient in the lateral decubitus position with the bleeding side dependent. Instillation of ice-cold saline or vasoconstrictors like epinephrine or vasopressin through the bronchoscope may be helpful. Wedging of the bronchoscope into the bleeding segment or use of endobronchial balloon tamponade should also be considered.

If these techniques are unsuccessful, bronchial artery embolization can be performed. Intubation using a double-lumen endotracheal tube may also be performed in an attempt to isolate the bleeding lung from the nonbleeding lung. Rarely, endobronchial instillation of sinoacrylate glue or oxidized, regenerated mesh has been used.

Hypoxemia may occur because of respiratory depression or the presence of obstructive sleep apnea (OSA). Suctioning during the procedure removes oxygen from the environment, and endobronchial insertion of the bronchoscope increases airway resistance, so supplemental oxygen should be provided through a nasopharyngeal tube or through the working channel of the bronchoscope. Reversal of sedation may also be helpful. Finally, intubation and mechanical ventilation may be necessary.

Pneumothorax may be detected during routine fluoroscopy and may require insertion of a chest tube.

Pneumonia and fever may occur following the procedure.

Proper disinfection of the bronchoscope is extremely important in preventing nosocomial transmission of tuberculosis and nontuberculosis mycobacterial infections and outbreaks of other notable infections, including those that are due to the Pseudomonas species. High-level bronchoscope disinfection is achieved using 2 percent glutaraldehyde, and sterilization may be achieved using ethylene oxide-based protocols.

What’s the evidence?

Bolliger, CT, Mathur, PN, Beamis, JF. "ERS/ATS statement on interventional pulmonology". Eur Respir J. vol. 19. 2002. pp. 356.

The published guidelines that defined interventional pulmonology for the first time. The statement suggests the requirements for each procedure and provides safety guidelines.

Feinsilver, SJ, Fein, AM. "Textbook of Bronchoscopy". William & Wilkens. 1995.

A classic textbook on basic bronchoscopy.

Vander Eerden, MM, Vlaspolder, F, de Graaff, CS. "Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia". Eur J Clin Microbiol Infect Dis. vol. 24. 2005. pp. 241.

An important paper that suggests the use of microbiological investigation in the evaluation of pneumonia.

Karmy-Jones, R, Cuschieri, J, Vallières, E. "Role of bronchoscopy in massive hemoptysis". Chest Surg Clin N Am. vol. 11. 2001. pp. 873.

An important paper that describes the use of bronchoscopy in evaluation of hemoptysis.

Feinsilver, SH, Fein, AM, Niederman, MS. "Utility of fiberoptic bronchoscopy in nonresolving pneumonia". Chest. vol. 98. 1990. pp. 1322.

Although published in 1990, this paper is the classic description of the use of bronchoscopy in the evaluation of nonresolving pneumonia.

Kvale, PA, Selecky, PA, Prakash, UB. "American College of Chest Physicians. Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines". Chest. vol. 132. 2007. pp. 368S.

This publication addresses evidence-based guidelines on the use of bronchoscopy for palliation in lung cancer.

Ernst, A, Eberhardt, R, Wahidi, M. "Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans". Chest. vol. 129. 2006. pp. 734.

A description of complications related to patient use of clopidogrel prior to transbronchial biopsy.
You must be a registered member of Psychiatry Advisor to post a comment.

Sign Up for Free e-newsletters